MAXN Investors Have Opportunity to Lead Maxeon Solar Technologies, Ltd. Securities Fraud Lawsuit – Maxeon Solar Technologies (NASDAQ:MAXN)

JJ Bounty







Opportunity for MAXN Investors in Maxeon Solar Technologies, Ltd. Securities Fraud Lawsuit

Rare Chance for MAXN Investors

LOS ANGELES, Aug. 15, 2024 – Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have an opportunity to lead the securities fraud class action lawsuit against Maxeon Solar Technologies, Ltd. (“Maxeon” or the “Company”) with the ticker symbol MAXN.

Class Period: November 15, 2023 – May 29, 2024
Lead Plaintiff Deadline: August 26, 2024

If you wish to serve as the lead plaintiff of the Maxeon lawsuit, you can submit your contact information at www.glancylaw.com/cases/Maxeon-Solar-Technologies-Ltd/. Contact Charles H. Linehan of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com for more information about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors critical information leading to a decrease in revenue, cash flow crisis, and misleading statements about the Company’s business and prospects.

For real-time updates, follow us on LinkedIn, Twitter, or Facebook.

To be a member of the class action, you need not take any action at this time. For inquiries, contact Charles Linehan, Esquire, of GPM, at 310-201-9150, Toll-Free at 888-773-9224, or by email at shareholders@glancylaw.com.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Cision View original content to download multimedia: Original Article Link

SOURCE Glancy Prongay & Murray LLP

Market News and Data brought to you by Benzinga APIs



See also  Exploring the Potential of Psilocybin: Tryp Therapeutics Advances in New TrialsExploring the Potential of Psilocybin: Tryp Therapeutics Advances in New Trials